← All candidates
54 insider filings on record.
54 filings on record.
PHVSPharvaris N.V.
NasdaqGS · Healthcare · $2.64B
$37.55
-1.34% today
54 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 30 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$2.64B
Float
43.7M
62% public
Short % float
Pro
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
49 more transactions on Pro →Context
Wall St
$58.64 avg target
+56.2% vs today · 14 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 3 quarters beat
Q2 '26−$0.70 act−$0.05
Q4 '25−$0.71 act−$0.09
Q3 '25−$0.60 act+$0.07
Coverage
PHVS Stock Rises 10% in a Month: What Is Driving the Rally?Zacks · 1d agoPharvaris (PHVS) Reports an 83% HAE Attack-Rate Reduction. Can Oral Convenience Win?Insider Monkey · 6d agoPharvaris Could Gain Hereditary Angioedema Market Share on Deucrictibant XR Data, RBC SaysMT Newswires · 1w agoPharvaris charts approval course for swelling disorder drug on Phase III winClinical Trials Arena · 1w ago
The file stays open
54 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice